I value being part of the largest and fastest growing user community of its kind in the world
Instem Client
Bridge Laboratories Implements Provantis 8™ In Record Timescales
Global Preclinical CRO, Bridge Laboratories, goes live with Provantis 8™ from Instem within 2 month timeframe.
CONSHOHOCKEN, PA - March 10th, 2009 - Instem, a leading provider of early drug development software solutions, is pleased to announce that Bridge Laboratories (Bridge) is now live with version 8 of Instem’s world-leading data collection, storage and reporting software, Provantis™, at their US facility.
Bridge provides US-level regulatory-compliant drug development services globally, with lab facilities in both the US and Beijing, China. In October 2008, Bridge confirmed their intention to upgrade to Provantis 8™ to harness the new functionality available in the latest release. Joy Kempton, Senior IT Manager at Bridge commented “We were extremely impressed with the new functionality available in Provantis 8. We decided to move to Provantis 8 to further improve efficiencies within our laboratory and to provide even quicker response times to our sponsors.”
Bridge has implemented the Provantis 8 In-Life, Reproductive Toxicology, Pathology, Dispense, Tables & Statistics, Protocol & Report Assembly and Clinical Pathology modules. They purchased a range of Professional Services from Instem, including Validation, Training and Installation services, to help them get into production faster and easier.
Provantis™ is a modern, fully integrated software system for single users and global organizations engaged in non-clinical evaluation studies. Orchestrating every facet of preclinical drug safety assessment, Provantis™ streamlines processes and workflows with straightforward, intuitive functionality for simple and complex studies within a GLP or non-GLP environment.
About Bridge Laboratories
Bridge Laboratories is a preclinical contract research organization (CRO) that provides US-level regulatory-compliant drug development services globally. Bridge is US owned with lab facilities in both the US and Beijing, China. Bridge is known for its extensive work in toxicology, including vaccines, developmental and reproductive toxicology (DART), and safety pharmacology. The company's AAALAC-accredited facility in China was among the first labs to perform GLP studies for clients worldwide.
About Instem
Instem is a world-leading information solutions provider for the Life Sciences – accelerating drug and chemical development by increasing client productivity and enhancing the processes that lead to safer, more effective products. In addition to highly focused departmental and scientific solutions, Instem provides a range of Business Intelligence, Planning, Workflow Management, Dosage Formulation, Document Management and Report Compilation applications.
Operating in a highly fragmented Life Sciences IT market, Instem is one of very few organizations that have developed the financial strength necessary to maintain a global leadership position with established products, while introducing new applications that can deliver the improvements in productivity that clients are aggressively pursuing.
Instem is committed to the exceptional customer experience. For more information on Instem and its solutions, please visit www.instem.com or contact them by email at info@instem.com.
Press Contact:
Instem
Automate. Accelerate. Discover.
Gary E. Mitchell
Tel: 610.941.0990
Email: gary.mitchell@instem.com
Links
Accessibility
Contact Us
© 2001 - 2010 Instem - All rights reserved